Sign in to view content

Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy Treated With Anti-VEGF Therapy and/or PRP in the United States

Rahul N. Khurana, MD, FASRS

Video
Published 2021

Related

Retinal Nonperfusion on Widefield OCTA in Determining Diabetic Retinopathy Severity
Annual Meeting Talks
2023
Level of Diabetic Retinopathy Severity Correlates to Degree of Quadrant Asymmetry in Both Single and Averaged Imaged OCTA Metrics
Jesse J Jung, MD, FASRS
Annual Meeting Talks
2022
Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Updates from the Field
2020

Category: Diabetic Retinopathy

See more